Comparison of vitamin D hydroxylation activities of rat CYP2J3 and human CYP2J2

被引:0
|
作者
Ohyama, Y [1 ]
Aiba, I [1 ]
Yamasaki, T [1 ]
Terato, H [1 ]
Ide, H [1 ]
机构
[1] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Japan
来源
Proceedings of the 14th International Conference on Cytochromes P450: Biochemistry, Biophysics, and Bioinformatics | 2005年
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant rat CYP2J3 and human CYP2J2 were successfully expressed in the E. coli expression system by co-expression of chaperone proteins. Purified proteins were applied to analysis of catalytic activities toward vitamin D compounds using a reconstituting system containing NADPH-P450 reductase. The CYP2J2 showed significant but about 10 times lower 25-hydroxylation activities than CYP2J3 toward vitamin D-3 and 1 alpha-OH-D-3. Interestingly, CYP2J2 prefers vitamin D-2 to vitamin D-3 as a substrate, whereas CYP2J3 did vitamin D-3 to vitamin D-2, The results suggest involvement of CYP2J subfamily proteins in vitamin D activation through 25-hydroxylation reaction, although they showed distinct preferences and activities toward vitamin D compounds.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条
  • [1] EVALUATION OF EBASTINE HYDROXYLATION AS A SPECIFIC PROBE OF CYP2J2 IN HUMAN LIVER MICROSOMES
    Yerino, Phyllis
    Toren, Paul
    Parkinson, Andrew
    DRUG METABOLISM REVIEWS, 2007, 39 : 323 - 324
  • [2] Terfenadine hydroxylation by recombinant CYP2J2 and 4F12
    Patten, C
    Gagne, P
    Miller, V
    Crespi, C
    Thummel, K
    DRUG METABOLISM REVIEWS, 2003, 35 : 121 - 121
  • [3] Roles of the epoxygenase CYP2J2 in the endothelium
    Askari, Ara
    Thomson, Scott J.
    Edin, Matthew L.
    Zeldin, Darryl C.
    Bishop-Bailey, David
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 107 : 56 - 63
  • [4] Variability of CYP2J2 expression in human fetal tissues
    Gaedigk, Andrea
    Baker, Darren W.
    Totah, Rheem A.
    Gaedigk, Roger
    Pearce, Robin E.
    Vyhlidal, Carrie A.
    Zeldin, Darryl C.
    Leeder, J. Steven
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (02): : 523 - 532
  • [5] THE ROLE OF CYP2J2 IN CYCLOPHOSPHAMIDE METABOLISM
    El-Serafi, I.
    Afsharian, P.
    Potacova, Z.
    Terelius, Y.
    Moshfegh, A.
    Hassan, M.
    HAEMATOLOGICA, 2013, 98 : 404 - 404
  • [6] Inhibitory Potential of Bilobetin Against CYP2J2 Activities in Human Liver Microsomes
    Wu, Zhexue
    Jang, Su-Nyeong
    Park, So-Young
    Nguyen Minh Phuc
    Liu, Kwang-Hyeon
    MASS SPECTROMETRY LETTERS, 2020, 11 (04) : 113 - 117
  • [7] The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2
    Tian, Xiangge
    Zhou, Meirong
    Ning, Jing
    Deng, Xiaopeng
    Feng, Lei
    Huang, Huilian
    Yao, Dahong
    Ma, Xiaochi
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 737 - 748
  • [8] INHIBITORY POTENTIAL OF THELEPHORIC ACID AND TSAHC ON CYP2J2 ACTIVITIES IN HUMAN LIVER MICROSOMES
    Wu, Zhexue
    Lee, Boram
    Kim, Se Yong
    Shon, Jong-Cheol
    Liu, Kwang-Hyeon
    Song, Kyung-Sik
    DRUG METABOLISM REVIEWS, 2015, 47 : 65 - 65
  • [9] Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues
    DeLozier, Tracy C.
    Kissling, Grace E.
    Coulter, Sherry J.
    Dai, Diana
    Foley, Julie F.
    Bradbury, J. Alyce
    Murphy, Elizabeth
    Steenbergen, Charles
    Zeldin, Darryl C.
    Goldstein, Joyce A.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (04) : 682 - 688
  • [10] Cloning of the CYP2J2 gene and identification of polymorphisms
    King, LM
    Ma, JX
    Srettabunjong, S
    Li, LP
    Zeldin, DC
    FASEB JOURNAL, 2000, 14 (08): : A1437 - A1437